This report has shown that BTK potentiates ALK-mediated signaling in neuroblastoma tumors, and combined treatment of ibrutinib with ALK inhibitor crizotinib can reduce the tumor growth of NB xenografts in nude mice. Here, ALK is linked to neuroblastoma.